In other cancer types, regarding PrP protein expression in pancreatic ductal adenocarcinoma patients, the PrP-positive group had a poorer prognosis than the PrP-negative group (log-rank test, p < 0.0001) [48]. This evidence concerns the gene PRNP and pancreatic ductal adenocarcinoma.